Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy.

Chong Chyn Chua,Andrew W. Roberts,John V. Reynolds,Chun Yew Fong,Stephen B Ting,Jessica M. Salmon,Sarah Macraild,Adam Ivey,Ing Soo Tiong,Shaun Fleming,Fiona C. Brown,Sun Loo,Ian J. Majewski,Stefan K Bohlander,Andrew Wei

Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy.

2020

Chong Chyn Chua
Andrew W. Roberts
John V. Reynolds
Chun Yew Fong
Stephen B Ting
Jessica M. Salmon
Sarah Macraild
Adam Ivey
Ing Soo Tiong
Shaun Fleming
Fiona C. Brown
Sun Loo
Ian J. Majewski
Stefan K Bohlander
Andrew Wei

PURPOSEThe B-cell lymphoma 2 (BCL-2) inhibitor venetoclax has an emerging role in acute myeloid leukemia (AML), with promising response rates in combination with hypomethylating agents or low-dose ...

Keywords:

intensive chemotherapy
dose escalation
Pathology
Lymphoma
Internal medicine
Myeloid leukemia
Medicine
Venetoclax
Chemotherapy
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations